Therapeutic and prognostic potential of GPCRs in prostate cancer from multi-omics landscape

Prostate cancer (PRAD) is a common and fatal malignancy. It is difficult to manage clinically due to drug resistance and poor prognosis, thus creating an urgent need for novel therapeutic targets and prognostic biomarkers. Although G protein-coupled receptors (GPCRs) have been most attractive for dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shiqi, Chen, Jianfang, Chen, Xin, Yu, Jin, Guo, Yanzhi, Li, Menglong, Pu, Xuemei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468875/
https://www.ncbi.nlm.nih.gov/pubmed/36110544
http://dx.doi.org/10.3389/fphar.2022.997664

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468875/
https://www.ncbi.nlm.nih.gov/pubmed/36110544
http://dx.doi.org/10.3389/fphar.2022.997664

Ejemplares similares